Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DS-01 Daily Synbiotic
- Development stage
- Unknown
- Lead developer
- Seed Health
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
DS-01 Daily Synbiotic is a consumer dietary supplement developed by Seed Health, a microbiome science company. It is a broad-spectrum synbiotic formulated with 24 clinically and scientifically studied probiotic strains (exclusively from the Lactobacillus and Bifidobacterium genera) combined with a non-fiber, polyphenol-based prebiotic derived from Indian pomegranate. DS-01 is delivered via a proprietary capsule-in-capsule system (ViaCap) designed to protect the live bacteria through digestion and ensure delivery to the colon. It is clinically validated to improve bowel regularity, reduce bloating, and alleviate gas, while also supporting gut barrier integrity, gastrointestinal immunity, cardiovascular health, and micronutrient synthesis. It is not FDA-approved to treat, cure, or prevent any disease.
- Brand names
- DS-01 Daily SynbioticDS01 Daily SynbioticDS 01 Daily Synbiotic
- Other names
- DS-01DS01DS 01Seed DS-01Seed DS-01 Daily Synbiotic
Beyond the preview
Go deeper on DS-01 Daily Synbiotic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DS-01 Daily Synbiotic.